Platelet TAU is Associated with Changes in Depression and Alzheimer's Disease
Open Access
- 12 May 2022
- journal article
- research article
- Published by IMR Press in Frontiers in Bioscience-Landmark
- Vol. 27 (5) , 153
Abstract
Background: Platelets (thrombocytes) are small anuclear cells that play an important role in blood clotting. They are activated and dysfunctional in brain disorders, such as Alzheimer’s disease (AD) and depression. Platelets express the amyloid-precursor protein (APP) and release beta-amyloid40 into the blood. Recent evidence reports that platelets also express the microtubule-associated protein tau. In this study, we further characterized the molecular appearance of tau and examined its alterations in patients with neurocognitive impairment. Methods: Platelets were isolated from patients with AD, mild cognitive impairment (MCI) or depression and compared to healthy controls. Subsequently, FACS analysis was employed to characterize platelets for platelet surface P-selectin (CD62P). In order to enhance the detection levels, samples were pooled (15 samples per group) and analyzed by Lumipulse Assay, Western blots, and mass spectrometry. Results: Tau is expressed in human platelets and tau levels were decreased in platelets isolated from patients with AD and depression. Additionally, phospho-tau-181 was slightly increased in patients with depression. We show that tau is highly fragmented (20–40 kDa) in the platelet extracts using Western blot analysis. The mass spectrometry data did not show a clear identification of tau in the pooled platelet samples. Conclusions: Our data reveal that tau is found in platelets, possibly in a highly fragmented form. Tau levels may be used as a potential diagnostic approach to differentiate AD and depression from healthy controls.Keywords
This publication has 54 references indexed in Scilit:
- Characterization of Novel CSF Tau and ptau Biomarkers for Alzheimer’s DiseasePLOS ONE, 2013
- Effects of oxidative stress on amyloid precursor protein processing in rat and human plateletsPlatelets, 2012
- Chronic mild cerebrovascular dysfunction as a cause for Alzheimer's disease?Experimental Gerontology, 2011
- Review: Sporadic cerebral amyloid angiopathyNeuropathology and Applied Neurobiology, 2010
- Tau phosphorylation: the therapeutic challenge for neurodegenerative diseaseTrends in Molecular Medicine, 2009
- Platelet function in patients with major depressionInternal Medicine Journal, 2009
- The Active Platelet: Translation and Protein Synthesis in an Anucleate CellSeminars in Thrombosis and Hemostasis, 2007
- Measurement of Thirteen Biological Markers in CSF of Patients with Alzheimer’s Disease and Other DementiasDementia and Geriatric Cognitive Disorders, 2005
- Depression, Alterations in Platelet Function, and Ischemic Heart DiseasePsychosomatic Medicine, 2005
- Neurovascular regulation in the normal brain and in Alzheimer's diseaseNature Reviews Neuroscience, 2004